138 related articles for article (PubMed ID: 10738698)
1. Niosomes as carriers of radiopaque contrast agents for X-ray imaging.
Muller D; Foulon M; Bonnemain B; Vandamme TF
J Microencapsul; 2000; 17(2):227-43. PubMed ID: 10738698
[TBL] [Abstract][Full Text] [Related]
2. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
Hasan AA
Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893
[TBL] [Abstract][Full Text] [Related]
3. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
4. Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability.
Manconi M; Valenti D; Sinico C; Lai F; Loy G; Fadda AM
Int J Pharm; 2003 Jul; 260(2):261-72. PubMed ID: 12842345
[TBL] [Abstract][Full Text] [Related]
5. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
[TBL] [Abstract][Full Text] [Related]
6. An electron spin resonance study of non-ionic surfactant vesicles (niosomes).
Yeom S; Shin BS; Han S
Chem Phys Lipids; 2014 Jul; 181():83-9. PubMed ID: 24721595
[TBL] [Abstract][Full Text] [Related]
7. Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes.
De Silva L; Fu JY; Htar TT; Muniyandy S; Kasbollah A; Wan Kamal WHB; Chuah LH
Int J Nanomedicine; 2019; 14():1101-1117. PubMed ID: 30863048
[TBL] [Abstract][Full Text] [Related]
8. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
9. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
Pardakhty A; Varshosaz J; Rouholamini A
Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
[TBL] [Abstract][Full Text] [Related]
10. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
11. Immuno-targeting of nonionic surfactant vesicles to inflammation.
Hood E; Gonzalez M; Plaas A; Strom J; VanAuker M
Int J Pharm; 2007 Jul; 339(1-2):222-30. PubMed ID: 17448616
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
[TBL] [Abstract][Full Text] [Related]
13. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.
Huang Y; Chen J; Chen X; Gao J; Liang W
J Mater Sci Mater Med; 2008 Feb; 19(2):607-14. PubMed ID: 17619962
[TBL] [Abstract][Full Text] [Related]
14. Formulation of resveratrol entrapped niosomes for topical use.
Pando D; Matos M; Gutiérrez G; Pazos C
Colloids Surf B Biointerfaces; 2015 Apr; 128():398-404. PubMed ID: 25766923
[TBL] [Abstract][Full Text] [Related]
15. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
Shaikh KS; Chellampillai B; Pawar AP
Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
[TBL] [Abstract][Full Text] [Related]
16. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
Abdelkader H; Ismail S; Kamal A; Alany RG
Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
[TBL] [Abstract][Full Text] [Related]
17. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
19. Novel method of niosome generation using supercritical carbon dioxide part I: process mechanics.
Wagner ME; Rizvi SS
J Liposome Res; 2015; 25(4):334-46. PubMed ID: 25945392
[TBL] [Abstract][Full Text] [Related]
20. Applying the Taguchi method to optimize sumatriptan succinate niosomes as drug carriers for skin delivery.
González-Rodríguez ML; Mouram I; Cózar-Bernal MJ; Villasmil S; Rabasco AM
J Pharm Sci; 2012 Oct; 101(10):3845-63. PubMed ID: 22806266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
